| |
| |
|
| Insider
Information: |
Melian Agustin |
| Relationship: |
EVP, Research & Develo... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
453,529 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$350,170 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
453,529 |
|
|
| Total
Value |
$350,170 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allovir Inc |
ALVR |
Chief Medical Officer |
2021-10-04 |
453,529 |
|
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
EVP, Research & Develo... |
2022-10-14 |
0 |
2022-07-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMTX |
Forma Therapeutics Holdin... |
EVP, Research & Development |
• – – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,000) |
0 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
EVP, Research & Development |
• – – |
2022-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
79,000 |
79,000 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-10-04 |
4 |
S |
$23.29 |
$446,862 |
D/D |
(18,689) |
453,529 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-09-28 |
4 |
AS |
$24.12 |
$90,432 |
D/D |
(3,750) |
472,218 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-09-17 |
4 |
AS |
$24.01 |
$70,842 |
D/D |
(2,950) |
475,968 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-09-15 |
4 |
AS |
$24.03 |
$19,224 |
D/D |
(800) |
478,918 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-07-02 |
4 |
AS |
$19.99 |
$371,534 |
D/D |
(18,586) |
479,718 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-04-05 |
4 |
AS |
$23.89 |
$435,085 |
D/D |
(18,212) |
498,304 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-03-22 |
4 |
AS |
$25.97 |
$97,394 |
D/D |
(3,750) |
516,516 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-02-02 |
4 |
S |
$41.19 |
$2,259,230 |
D/D |
(54,849) |
520,266 |
0 |
% |
|
| ALVR |
Allovir Inc |
Chief Medical Officer |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
575,115 |
0 |
- |
|
| ALVR |
Allovir Inc |
Chief Medical OfficerOfficer |
• – – |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
531,365 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
